We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$376M
AUM Growth
-$49.9M
Cap. Flow
-$71.2M
Cap. Flow %
-18.95%
Top 10 Hldgs %
30.78%
Holding
247
New
89
Increased
32
Reduced
48
Closed
42

Top Buys

Rank Stock Value
1
WBS icon
Webster Financial
WBS
+$8.18M
2
NFLX icon
Netflix
NFLX
+$8.12M
3
RH icon
RH
RH
+$7.6M
4
EBAY icon
eBay
EBAY
+$7.58M
5
TSLA icon
Tesla
TSLA
+$7.04M

Top Sells

Rank Stock Value
1
ASH icon
Ashland
ASH
+$11.5M
2
FFIV icon
F5
FFIV
+$10.4M
3
HCA icon
HCA Healthcare
HCA
+$9.96M
4
MMM icon
3M
MMM
+$9.59M
5
MCK icon
McKesson
MCK
+$9.56M

Sector Composition

Rank Sector Weight
1 Healthcare 19.36%
2 Consumer Discretionary 15.29%
3 Consumer Staples 11.75%
4 Financials 11.45%
5 Technology 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
176
Mondelez International
MDLZ
$79.9B
$2K ﹤0.01%
+44
New +$1.97K
MET icon
177
MetLife
MET
$62.1B
$2K ﹤0.01%
+46
New +$2.02K
MO icon
178
Altria Group
MO
$114B
$2K ﹤0.01%
+34
New +$1.97K
MSFT icon
179
Microsoft
MSFT
$3.71T
$2K ﹤0.01%
+42
New +$2.21K
NKE icon
180
Nike
NKE
$61.9B
$2K ﹤0.01%
+30
New +$1.94K
PFE icon
181
Pfizer
PFE
$153B
$2K ﹤0.01%
+61
New +$1.92K
PM icon
182
Philip Morris
PM
$295B
$2K ﹤0.01%
+23
New +$2K
PNC icon
183
PNC Financial Services
PNC
$101B
$2K ﹤0.01%
+22
New +$2.04K
PRU icon
184
Prudential Financial
PRU
$41.8B
$2K ﹤0.01%
+25
New +$2.07K
PSX icon
185
Phillips 66
PSX
$81.4B
$2K ﹤0.01%
+24
New +$2.07K
REGN icon
186
Regeneron Pharmaceuticals
REGN
$80.8B
$2K ﹤0.01%
+4
New +$2.17K
SBUX icon
187
Starbucks
SBUX
$120B
$2K ﹤0.01%
+33
New +$2.01K
SCHW
188
Charles Schwab
SCHW
$187B
$2K ﹤0.01%
+69
New +$2.18K
SPG icon
189
Simon Property Group
SPG
$72.3B
$2K ﹤0.01%
+10
New +$1.94K
TGT icon
190
Target
TGT
$68B
$2K ﹤0.01%
+26
New +$1.94K
TMO icon
191
Thermo Fisher Scientific
TMO
$220B
$2K ﹤0.01%
+16
New +$2.13K
TXN icon
192
Texas Instruments
TXN
$261B
$2K ﹤0.01%
+35
New +$1.95K
UNH icon
193
UnitedHealth
UNH
$370B
$2K ﹤0.01%
16
-64
-80% -$7.48K
USB icon
194
US Bancorp
USB
$99.6B
$2K ﹤0.01%
+47
New +$2.01K
V icon
195
Visa
V
$677B
$2K ﹤0.01%
+26
New +$2.01K
WBA
196
DELISTED
Walgreens Boots Alliance
WBA
$2K ﹤0.01%
+23
New +$1.95K
WFC icon
197
Wells Fargo
WFC
$264B
$2K ﹤0.01%
+37
New +$2.01K
AGN
198
DELISTED
Allergan plc
AGN
$2K ﹤0.01%
+7
New +$2.08K
ESRX
199
DELISTED
Express Scripts Holding Company
ESRX
$2K ﹤0.01%
+23
New +$1.97K
AET
200
DELISTED
Aetna Inc
AET
$2K ﹤0.01%
+18
New +$1.95K

Similar funds

Contravisory Investment Management's Q4 2015 Portfolio in Review

As of Q4 2015, Contravisory Investment Management held 247 positions worth $376M, down 12% from $425M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Contravisory Investment Management withdrew a net $71.2M in Q4 2015, closing 42 positions and reducing 48 holdings. Its most notable exit was F5, an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Contravisory Investment Management opened a new position in Webster Financial worth $8.03M.

  • Contravisory Investment Management's largest Q4 2015 buy was Webster Financial: 215,895 shares worth $8.03M.
  • Contravisory Investment Management added most to State Street Technology Select Sector SPDR ETF in Q4 2015, an estimated $719K increase.
  • Contravisory Investment Management's biggest Q4 2015 reduction was Ashland, cutting an estimated $11.5M.
  • Contravisory Investment Management fully exited F5 in Q4 2015, selling an estimated $10.4M.
  • Contravisory Investment Management's ten largest holdings make up 31% of its $376M portfolio in Q4 2015.
  • Contravisory Investment Management opened 89 new positions and closed 42 in Q4 2015.
  • Contravisory Investment Management's portfolio value fell 12% quarter-over-quarter to $376M.

Based on Contravisory Investment Management's 13F filing for Q4 2015, filed 12 Jan 2016.